These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 10050509

  • 21. [Comparative antisecretory activity of famotidine, omeprazole, and rabeprazole (pariet) in ulcer disease based on daily pH-monitoring].
    Rakov AL, Makarov IuS, Gorbakov VV, Mironenko DA, Golochalova TV.
    Voen Med Zh; 2001 Sep; 322(9):54-8. PubMed ID: 11668793
    [No Abstract] [Full Text] [Related]

  • 22. [Pharmacotherapy of non-associated with Helicobacter pylori ulcer].
    Grinevich VB, Uspenskiĭ IuP, Shabanova GZh, Sablin OA, Shcherbina NN.
    Klin Med (Mosk); 2002 Sep; 80(10):44-6. PubMed ID: 12471838
    [Abstract] [Full Text] [Related]

  • 23. Clinical efficacy of famotidine in the treatment of acid-related diseases: an overview.
    Dammann HG.
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():2-5. PubMed ID: 2210612
    [Abstract] [Full Text] [Related]

  • 24. Peptic ulcer. A follow-up study.
    Bank L, Wright JP, Lucke W, Marks IN.
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):381-4. PubMed ID: 2876024
    [Abstract] [Full Text] [Related]

  • 25. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K, Watanabe T, Tominaga K, Shiba M, Nakagawa K, Uno H, Kitada K, Satoh H, Chono S, Uchida T, Fujiwara Y, Arakawa T.
    Int J Clin Pharmacol Res; 2005 Jun; 25(4):187-94. PubMed ID: 16402635
    [Abstract] [Full Text] [Related]

  • 26. [The effect of cimetidine and famotidine on esophageal motility].
    Paradowski L, Salomon A, Szelag A.
    Pol Tyg Lek; 1996 Apr; 51(14-18):227-9. PubMed ID: 8966165
    [Abstract] [Full Text] [Related]

  • 27. [H2-blockers of histamine receptors in the therapy of early stages of gastroduodenal reflux disease].
    Lazebnik LB, Vasil'ev IuV, Masharova AA, Zelenkin SA, Ianova OB.
    Eksp Klin Gastroenterol; 2004 Apr; (6):47-51, 164. PubMed ID: 16259441
    [Abstract] [Full Text] [Related]

  • 28. [Gastroprotective effects of histamine H2-receptor blockers in Helicobacter-like gastric mucosa lesions].
    Spasov AA, Chernikov MV, Speranskaia AS, Zaĭchenko SI.
    Eksp Klin Gastroenterol; 2005 Apr; (6):24-7, 111-2. PubMed ID: 17378382
    [Abstract] [Full Text] [Related]

  • 29. [New antisecretory drugs in the treatment of ulcer].
    Sheptulin AA.
    Klin Med (Mosk); 1994 Apr; 72(1):12-5. PubMed ID: 7910870
    [No Abstract] [Full Text] [Related]

  • 30. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
    Pal'tsev AI, Maslennikova TA.
    Ter Arkh; 1997 Apr; 69(2):62-3. PubMed ID: 9173582
    [No Abstract] [Full Text] [Related]

  • 31. Histamine H2-receptor antagonists.
    Pounder R.
    Baillieres Clin Gastroenterol; 1988 Jul; 2(3):593-608. PubMed ID: 2901868
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of famotidine and ranitidine in duodenal ulcer].
    Rohner HG, Gugler R, Kimmig JM, Schönekäs H.
    Dtsch Med Wochenschr; 1987 Feb 27; 112(9):367-8. PubMed ID: 2880704
    [No Abstract] [Full Text] [Related]

  • 33. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
    Wu CS, Wang SH, Chen PC, Wu VC.
    Int J Clin Pract; 1998 Oct 27; 52(7):472-4. PubMed ID: 10622088
    [Abstract] [Full Text] [Related]

  • 34. Unusual erythemas with eosinophilia, caused by H2-blocker famotidine in a male patient with glioblastoma.
    Horiuchi Y, Bae SJ, Katayama I, Hayashi Y.
    J Dermatol; 2004 Jul 27; 31(7):577-9. PubMed ID: 15492426
    [No Abstract] [Full Text] [Related]

  • 35. A single nocte dose of famotidine in the treatment of duodenal ulcer.
    Qureshi H, Ahmad W, Zuberi SJ.
    J Pak Med Assoc; 1989 Apr 27; 39(4):104-6. PubMed ID: 2568508
    [Abstract] [Full Text] [Related]

  • 36. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G.
    Clin Ter; 1984 Mar 31; 108(6):525-9. PubMed ID: 6144411
    [No Abstract] [Full Text] [Related]

  • 37. [Surgical treatment of gastroduodenal ulcer disease. Our experience after the advent of H2-antagonist drugs].
    Carrella G, Salomoni C, De Anna D, Pozza E, Sortini A, Guerrera C, Pansini GC, Marcello D, Vettorello GF.
    Minerva Chir; 1987 Oct 15; 42(19):1483-5. PubMed ID: 2891084
    [No Abstract] [Full Text] [Related]

  • 38. Combination sucralfate and histamine2-antagonist therapy.
    Gales MA, Steadman BK.
    Ann Pharmacother; 1994 May 15; 28(5):597-600. PubMed ID: 7915150
    [No Abstract] [Full Text] [Related]

  • 39. [Rational pharmacotherapy in gastric ulcer].
    Rune SJ.
    Nord Med; 1982 Mar 15; 97(3):72-3. PubMed ID: 6121317
    [No Abstract] [Full Text] [Related]

  • 40. [Peptic ulcer: changes in the surgical approach after the introduction of H2-antagonists in clinical practice].
    Rimassa PL, Marino G, Quartapelle V, D'Asta F, Maggiolo G, Manno A, Piffero D, Schiappacasse E.
    Minerva Chir; 1987 Oct 15; 42(19):1499-502. PubMed ID: 2891087
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.